Pathways in the diagnosis and management of diabetic polyneuropathy - Wikidata - awgldk - TriplyDB

Pathways in the diagnosis and management of diabetic polyneuropathy

Pathways in the diagnosis and management of diabetic polyneuropathy

http://www.wikidata.org/entity/Q28082465

about

Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy.Lipoic Acid Use and Functional Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke and Diabetes.Stem Cells for Diabetes Complications: A Future Potential Cure.

P2860

Q33621822-C2D0D1D1-36FD-454D-B0D8-9637F4916E08 Q36123798-C3CBF06B-5853-439C-9DEB-136D83D61DCA Q36146154-C7139053-7947-4322-BBC9-8D6825EC741F Q38759783-D152A599-9701-436E-A1D8-B7F09B5FD19B

P2860

Pathways in the diagnosis and management of diabetic polyneuropathy

http://www.wikidata.org/entity/Q28082465

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pathways in the diagnosis and management of diabetic polyneuropathy

@ast

Pathways in the diagnosis and management of diabetic polyneuropathy

@en

Pathways in the diagnosis and management of diabetic polyneuropathy

@nl

type

label

Pathways in the diagnosis and management of diabetic polyneuropathy

@ast

Pathways in the diagnosis and management of diabetic polyneuropathy

@en

Pathways in the diagnosis and management of diabetic polyneuropathy

@nl

prefLabel

Pathways in the diagnosis and management of diabetic polyneuropathy

@ast

Pathways in the diagnosis and management of diabetic polyneuropathy

@en

Pathways in the diagnosis and management of diabetic polyneuropathy

@nl

P1433

Q28082465-FD89292E-0736-43CB-BBB9-C1FDE919BEDB

P1476

Q28082465-69917F20-8084-41A6-BB23-E4303C1A3679

P2093

Q28082465-0B515E44-7046-45F1-A7D2-E9399F6D9783

Q28082465-7EE1C366-8623-4D3A-A101-93CE59B33EF8

Q28082465-7F33E8F4-9B64-4DD1-873C-77034AC5BA41

P275

Q28082465-60150AAF-A174-4673-8DEE-0CAB8B6A679F

P2860

Q28082465-0087412C-751E-4EA7-A494-9A42081A9B18

Q28082465-057AAB6B-BDCF-4FEA-9B88-C45E918D92E9

Q28082465-05FDF3CD-94A8-4BF6-8EDA-3870BC61D68E

Q28082465-0719AC62-F82F-4A1F-AFEE-AF77FE8F48E3

Q28082465-08AD8EDB-65A7-45F3-82A0-C1947E9F7F89

Q28082465-0DD1A1A7-01CE-4FFB-AE9A-E463B3B5FF0A

Q28082465-0E6659C3-7B0F-455E-B28B-7DCA0D156F3C

Q28082465-11BC3094-6294-45DD-8D50-DCA358399F3E

Q28082465-13AA39C4-E121-4F6F-8D2F-AEBF26BAAF60

Q28082465-13CE6DB9-A43E-4E65-B0F5-0C5BBD7CD39C

P2888

Q28082465-661EE159-FC4E-4F38-9EFC-550A179A5014

P304

Q28082465-2A611F85-3EB5-48D1-8DE3-0A1483488C86

P31

Q28082465-058470AB-6095-42EB-B045-E1FFC8075F5C

Q28082465-BDADAE51-88E1-4224-9B82-A31D660DA71C

P3181

Q28082465-F37D601D-3DF9-42A5-BDC6-9C5EB624F0EB

P356

Q28082465-25C7154A-9E27-4253-9CA1-BFDD5B41F056

P407

Q28082465-696E25E6-194B-4824-8D41-3024ABD4994E

P433

Q28082465-0DC25075-3BDC-4EEB-9031-540F2DAC5E80

P478

Q28082465-C8EA7E9A-39E0-427D-857A-E591E5B6F7FB

P5008

Q28082465-F5EDA458-3398-41BD-9619-50D8FC40AB7A

P577

Q28082465-376154FA-BB0F-429E-946F-3CCF31887E25

Q28082465-89BCEF7E-E06B-4A41-80AB-30A1DBBD4161

P5875

Q28082465-1493A0CD-24F0-42ED-A13F-A29BFF928157

P6179

Q28082465-C236073F-6757-46FD-B277-5BC812B18779

P698

Q28082465-9FDF283F-794A-4DBF-BDA3-83E0352BEDB4

P921

Q28082465-7A3CA0A9-4D3F-460F-B5A3-6CDCD8AEE12F

P932

Q28082465-E2CDC6C2-C047-42BB-BCD1-1D99A38A9473

P3181

P356

S11892-015-0609-2

P1433

Current diabetes report

P1476

Pathways in the diagnosis and management of diabetic polyneuropathy

@en

P2093

Aaron Vinik

http://www.w3.org/2001/XMLSchema#string

David M. Simpson

http://www.w3.org/2001/XMLSchema#string

Michelle Kaku

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials

Topical capsaicin (high concentration) for chronic neuropathic pain in adults

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitati

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

Small fiber neuropathy: A burning problem

Mitochondrial stress and the pathogenesis of diabetic neuropathy

Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.

The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology.

P2888

s11892-015-0609-2

P304

609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3323692

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11892-015-0609-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275362919

http://www.w3.org/2001/XMLSchema#string

P6179

1041407297

http://www.w3.org/2001/XMLSchema#string

P698

25899758

http://www.w3.org/2001/XMLSchema#string

P921

diabetic neuropathy

P932

4440893

http://www.w3.org/2001/XMLSchema#string